1st Quarter - Report

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Waste (hazardous/solid/interstate/nuclear) WAS

Communication to the Environmental Protection Agency on Preliminary 2010 Effluent Guidelines Program Plan and the disposal of unused pharmaceuticals.

LobbyistCovered position, as disclosed
JUSTINE COFFEY —
JOSEPH M HILL —
BRIAN M MEYER —
GERALYN TRUJILLO —

Contacted: Food & Drug Administration (FDA); SENATE; Agency for Healthcare Research & Quality (AHRQ); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Health Issues HCR

Labor-Health and Human Services Appropriations fiscal years 2010 and 2011. H.R. 3590, Patient Protection and Affordable Care Act, Title III, all provisions relating to "medication therapy management," "medical home," and "independence at home." H.R. 3962, Affordable Health Care for America Act, Title II, all provisions relating to Frontline Health Providers and Loan Forgiveness; Title III, all provisions relating to "medical home" and "independence at home;" Title V, all provisions relating to "medication therapy management." Communications to House and Senate supporting residency funding. Communicatins with FDA regarding the Safe Use Initiative; Communications with FDA regarding inpatient distribution of Medication Guides; Communication with FDA on Transparency Task Force; Communication with FDA on appointment of Special Government Employees.

LobbyistCovered position, as disclosed
JUSTINE COFFEY —
JOSEPH M HILL —
BRIAN M MEYER —
GERALYN TRUJILLO —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); Environmental Protection Agency (EPA); SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 3962 (111th), H.R. 3590 (111th)

Medicare/Medicaid MMM

Communication with Centers for Medicare and Medicaid Services on chemotherapy administration codes, physician supervision requirements, and anticoagulation billing issue; Communications to CMS and Office of the National Coordinator for Health Information Technology on issues relating to health information technology and meaningful use.

LobbyistCovered position, as disclosed
JUSTINE COFFEY —
JOSEPH M HILL —
BRIAN M MEYER —
GERALYN TRUJILLO —

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Agency for Healthcare Research & Quality (AHRQ)

Pharmacy PHA

Communication with FDA regarding the quality of compounded drugs and improving stakeholder communications; Communications to the Agency for Healthcare Research and Quality regarding nominations to Effective Healthcare Stakeholder Group; Communication with FDA on Risk Evaluation and Mitigation Strategies and Prescription Drug User Fee Act Reauthorization Public Meeting.

LobbyistCovered position, as disclosed
JUSTINE COFFEY —
JOSEPH M HILL —
BRIAN M MEYER —
GERALYN TRUJILLO —

Contacted: Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.